Evidence map›Paper›PMID 38271991›Full record

ArticleACS infectious diseases2024

Enhanced Antimalarial and Antisequestration Activity of Methoxybenzenesulfonate-Modified Biopolymers and Nanoparticles for Tackling Severe Malaria.

Adrian Najer, Junyoung Kim, Catherine Saunders, Junyi Che, Jake Baum, Molly M Stevens

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Adrian NajerDepartment of Materials, Department of Bioengineering, and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K.ORCID 0000-0003-4868-9364
Junyoung KimDepartment of Materials, Department of Bioengineering, and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K.
Catherine SaundersDepartment of Materials, Department of Bioengineering, and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K.ORCID 0009-0000-3883-9635
Junyi CheDepartment of Materials, Department of Bioengineering, and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K.
Jake BaumDepartment of Life Sciences, Imperial College London, London SW7 2AZ, U.K.
Molly M StevensDepartment of Materials, Department of Bioengineering, and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K.ORCID 0000-0002-7335-266X
Imperial College London · GBUniversity of Oxford · GB

Funding

Wellcome Trust 209121/Z/17/Z
6 · The paper itself

Abstract

Severe malaria is a life-threatening condition that is associated with a high mortality. Severe

Indexed as

AntimalarialsMalaria, CerebralBiopolymersEndothelial CellsFemaleHeparinHumansPlacentaPlasmodium falciparumPregnancyAntimalarialsBiopolymersHeparinbiomaterialinhibitionnanoparticlePlasmodiumsequestrationsevere malaria

Identifiers

PMID38271991
PMCPMC10862538
OpenAlexW4391243943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.